Literature DB >> 16387119

Interferon alpha-2B and liver resection to treat multifocal hepatic epithelioid hemangioendothelioma: a relevant approach to avoid liver transplantation.

F H F Galvão1, A Bakonyi-Neto, M A C Machado, A Q Farias, E S Mello, M E Diz, M C C Machado.   

Abstract

BACKGROUND: Hepatic epithelioid hemangioendothelioma is a rare malignant tumor of vascular origin with frequent multifocal appearance. Liver resection may cause tumor spread. Liver transplantation has been indicated for unresectable nodules. We hypothesized that adjuvant interferon treatment is effective to prevent metastasis after liver resection. We report a case of multifocal hepatic epithelioid hemangioendothelioma successfully treated with interferon pulse therapy and bilobar hepatic resection.
METHODOLOGY: CT scan and magnetic resonance imaging diagnosed three nodules in the liver (segments IV, VI and VII). Histopathology and specific immunostaining of a percutaneous nodule biopsy confirmed the diagnosis of hepatic epithelioid hemangioendothelioma. The treatment protocol included daily interferon alpha 2b 9 weeks before and 1 week after resection of liver segments IV, VI and VII.
RESULTS: The postoperative outcome was complicated by a self-limited biliary fistula. The patient remains tumor free at 3 years after liver resection and currently enjoys excellent health.
CONCLUSION: Interferon pulse therapy and hepatic resection was a good option to treat multifocal bilobar hepatic epithelioid hemangioendothelioma; it may prevent metastasis dissemination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16387119     DOI: 10.1016/j.transproceed.2005.11.022

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  15 in total

1.  Two-stage treatment with hepatectomy and carbon-ion radiotherapy for multiple hepatic epithelioid hemangioendotheliomas.

Authors:  Shohei Komatsu; Takeshi Iwasaki; Yusuke Demizu; Kazuki Terashima; Osamu Fujii; Atsushi Takebe; Akihiro Toyokawa; Kazuhiro Teramura; Takumi Fukumoto; Yonson Ku; Nobukazu Fuwa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients.

Authors:  Long-Rong Wang; Jia-Min Zhou; Yi-Ming Zhao; Hong-Wei He; Zong-Tao Chai; Miao Wang; Yuan Ji; Yi Chen; Chen Liu; Hui-Chuan Sun; Wei-Zhong Wu; Qing-Hai Ye; Jian Zhou; Jia Fan; Zhao-You Tang; Lu Wang
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

3.  Hepatic epithelioid hemangioendothelioma after thirteen years' follow-up: A case report and review of literature.

Authors:  Wei-Fang Mo; Yu-Ling Tong
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

4.  Surgical Therapy for a Solitary Form of Hepatic Epithelioid Hemangioendothelioma: A Long-Term Survival Case.

Authors:  Nobu Oshima; Hiroaki Terajima; Ryo Hosotani
Journal:  Case Rep Gastroenterol       Date:  2009-08-28

5.  Multifocal epitheloid hemangioendothelioma of liver after long-term oral contraceptive use--a case report and discussion of management difficulties encountered.

Authors:  Shashideep Singhal; Shilpa Jain; Montish Singla; Ram Babu Pippal; Ranjana Gondal; Anil Agarwal; Premashis Kar
Journal:  J Gastrointest Cancer       Date:  2009-08-27

6.  Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma.

Authors:  Ryan M Thomas; Thomas A Aloia; Mark J Truty; Warren H Tseng; Eugene A Choi; Steven A Curley; Jean N Vauthey; Eddie K Abdalla
Journal:  HPB (Oxford)       Date:  2013-12-06       Impact factor: 3.647

7.  Epithelioid hemangioendothelioma of the liver.

Authors:  Keum Ha Choi; Woo Sung Moon
Journal:  Clin Mol Hepatol       Date:  2013-09

8.  Post-resection prognosis of patients with hepatic epithelioid hemangioendothelioma.

Authors:  Byeong-Gon Na; Shin Hwang; Chul-Soo Ahn; Ki-Hun Kim; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Seung-Mo Hong; Sung-Gyu Lee
Journal:  Ann Surg Treat Res       Date:  2021-02-26       Impact factor: 1.859

9.  Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib.

Authors:  Bruno Sangro; Mercedes Iñarrairaegui; Nerea Fernández-Ros
Journal:  Rare Tumors       Date:  2012-06-15

10.  Long term follow up after resection emphasizes the role of surgery in Primary Hepatic Epithelioid Hemangioendothelioma.

Authors:  Arianeb Mehrabi; Katrin Hoffmann; Karl Heinz Weiss; Carolin Mogler; Peter Schemmer; Markus W Büchler; Ingo Alldinger
Journal:  Ann Med Surg (Lond)       Date:  2016-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.